Market Analysis - Adv.Biotech 2018
Today’s Market Study of Bioscience in USA | Europe | Middle East | Asia Pacific
USA: Biotechnology expected market worth is $5,030.4 Million by 2018 and US$12.4 Billion by 2019 due to Increasing Demand for Enhanced Vaccines and Drugs and is expected to grow with a CAGR of 33.4% during 2015-2020.
Europe: The Biotechnology market report in 2013 is $1,723.1 and is expected to reach $4,430.4 Million by 2018 and 30.60% CAGR till 2019, growing at a CAGR of 22% during the forecast period.
Middle East: The Biotechnology market was valued at $2,823.9 million in 2014, and it is expected to grow with a CAGR of 37.9% during the period 2016 - 2021.
Asia Pacific: The Asia pacific Biotechnology market was valued at $ 4,845.7 million in 2015 and Expected to Reach USD12.4 Billion in 2019, growing at a CAGR of 22% during the forecast period.
We are delighted to invite you all to attend and register for the “4th International Conference on Advances in Biotechnology and Bioscience" ( Adv.Biotech 2018) which is going to be held during November 15-17, 2018 at Frnakfurt, Germany.
The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Adv.Biotech 2018, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Adv.Biotech 2018 organizing committee look forward to meeting you in Frankfurt.
Academicians, Scientists & Business delegates, Experts, Departmental Managers, Vice Presidents/ Directors & Brand Manufacturers/ Marketers of Consumer Products. Solution Providers (digital and mobile technology), Professors and Students from Academia in the study of Biotechnology and Bioscience.
Glance at Market of Advertising and Marketing:
This report studies the global bioscience market for the forecast period of 2013 to 2018. This market is expected to reach $5,030.4 million by 2018 from $1,923.1 million in 2013, growing at a CAGR of 23% during the forecast period.
The global biotechnology market is segmented on the basis of tools, technologies, applications, and geographies.
On the basis of technologies, the Biotechnology market is segmented into enabled and enabling technologies. Enabling technologies accounted for a major share of the Biotechnology market in 2013. On the basis of applications, the biotechnology market is segmented into environmental, medical, and industrial applications. The medical applications segment accounted for a major share of the biotechnology in 2016.